Multiple conformations and supramolecular synthons in almost fifty crystal structures of the anti-HIV/HBV drug lamivudine
Journal of Molecular Structure, ISSN: 0022-2860, Vol: 1181, Page: 157-170
2019
- 9Citations
- 13Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Review Description
Lamivudine (β-L-2′,3′-dideoxy-3′-thiacytidine, 3 TC), is one of the most investigated drugs in the fields of solid state chemistry and crystal engineering. Already in the year 1996, there was the first report of two crystal forms of lamivudine. Since then, more than 45 solid forms have been discovered, totaling 47 different arrangements of the same drug in the solid state (4 true polymorphs, 2 hydrates, 22 salts, 7 cocrystals, 5 cocrystals of salts, 6 so-called duplexes and 1 solid solution). Lamivudine has received much attention and there are numerous publications on its solid state forms, which have indeed brought important advances in our knowledge about solid state structure and improvement of pharmaceutical performance, but have also introduced challenges with respect to analysis and reproducibility. The purpose of this review is to describe all lamivudine solid forms currently known, focusing on their structural features. The description and occurrence of all 5’-CH 2 OH conformations, oxathiolane puckers and supramolecular synthons in all available lamivudine crystal forms is presented here. These structural information and characterization data will be useful for pharmaceutical design and analysis, as well as demonstrating the applicability of crystal engineering strategies to drugs with the same motifs as lamivudine.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0022286018315333; http://dx.doi.org/10.1016/j.molstruc.2018.12.099; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85059615981&origin=inward; https://linkinghub.elsevier.com/retrieve/pii/S0022286018315333; https://api.elsevier.com/content/article/PII:S0022286018315333?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S0022286018315333?httpAccept=text/plain; https://dul.usage.elsevier.com/doi/; https://dx.doi.org/10.1016/j.molstruc.2018.12.099
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know